Five years after the introduction of the $1,000 genome, the sequencing field remains rife with chatter about pushing the cost much lower—not only to $100...
Helomics will provide CRO services and its D-CHIP artificial intelligence (AI) platform for a functional precision medicine study called PIONEER sponsored by SpeciCare.
The study validates that real-world data obtained from routine clinical care to create a multi-institution clinico-genomic database can yield clinically meaningful insights.
CRC tumors can switch off expression of a cell surface molecule that is a key target of immunotherapy, thus preventing the treatment from working.
The classifier could help to flag patients who are most likely to have familial hypercholesterolemia, so that they and their families can undergo further genetic testing.
Clinico-genomic research study aims to improve personalized treatments for people with multiple sclerosis DNAnexus, UPMC, and Sutter Health network said today they have launched a...
The AI platform from Notable completed personalized treatment recommendations for all 20 patients within 30 days demonstrating both a positive and negative predictive value average of 84 percent.
Evotec and Individumed said today they will partner to develop new precision therapeutics for colorectal cancer (CRC), through a collaboration whose value was not...
Up-and-Coming Diagnostic Test Developers Emerge as Consolidation Thins the Field.
The agency said it is unaware of data establishing that Inova’s tests helps patients or clinicians make appropriate treatment decisions for the listed drugs.